Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SH T00658ID versus SH D593B for primary dysmenorrhea in women requesting oral contraception
2008-005625-11Phase 3Completed
- Sponsor
- Bayer
- Start
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of estradiol valerate + dienogest in primary dysmenorrhea (PD) (2 arms), sponsored by Bayer. Primary endpoint: Absolute change in days with dysmenorrheic pain. Started Apr 2009; status: completed.
02
Drugs
estradiol valerate + dienogest
03
Conditions
primary dysmenorrhea (PD)
Beyond the preview
Go deeper on 2008-005625-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005625-11.